Category Archives: Whistleblower
New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions
Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...
Actos Side Effects Lawyers Says Whistleblower Revelations Could Boost Bladder Cancer, Heart Failure Lawsuits
An attorney with a prominent personal injury law firm says an Actos whistleblower lawsuit filed earlier this year could strengthen legal claims alleging the type 2 diabetes medication caused some users to develop bladder cancer and heart failure.
Smokers More Vulnerable to Joint Replacement Failures
People who smoke cigarettes before and after receiving a total joint replacement, such as a hip replacement device or knee implant, are far more likely to endure revision surgeries on those implants than people who don’t smoke.
Tennessee Resident Files Pradaxa Bleeding Lawsuit Following Cerebral Hemorrhage
A man from Tennessee has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage. The complaint alleges Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause Serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects ...
Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit
A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit
A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...
Federal DePuy ASR Hip Implant Trials Likely to Start This Year
It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...
Actos Bladder Cancer Lawsuit Filed by West Virginia Resident
Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...
First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL
The first test trials in the federal C.R. Bard Avaulta transvaginal mesh litigation will most likely start next year, according to a report from Bloomberg News. About 600 lawsuits involving Bard Avaulta transvaginal mesh products are currently pending in the multidistrict litigation underway Charleston, West Virginia. U.S. District Judge Joseph ...
Fracking Boom Changing Way of Life in Pennsylvania's Northern Tier
In just a few years, the impact of hydraulic fracturing (fracking) drilling on northeastern Pennsylvania is hard to miss. Thousands of natural gas wells have been opened in that area specifically in the last five years as companies look to exploit the vast Marcellus shale formation about two miles below the ...
Rituxan Whistleblower Lawsuit Settled For $20 Million
A Rituxan whistleblower lawsuit has been settled for $20 million dollars. The settlement mandates Genentech pay due to illegal off-label marketing of its cancer drug. The settlement, completed last month, is expected to net $5.7 million for whistleblower, John Underwood, … Continue reading
DOJ Takes Over Stent Whistleblower Lawsuit
A recent study revealed that less than half of all Americans with stable heart disease should receive guideline-recommended medicines before undergoing angioplasty with coronary stent—a procedure also known as percutaneous coronary intervention or PCI. The ProPublica study suggested that the … Continue reading
Depakote Marketing Settlement Being Negotiated
Abbott Laboratories (ABT) is in talks to settle a U.S. Department of Justice (DOJ) probe into whether or not it illegally marketed < "http://www.yourlawyer.com/topics/overview/depakote">Depakote, its anti-seizure medication for nonapproved uses, said the Wall Street Journal, citing a court department. We … Continue reading
SEC Grants Final Approval To Whistleblower Rules
Under new Securities and Exchange Commission (SEC) approval, securities fraud whistleblowers could potentially earn millions of dollars in payouts, said the LA times. A whistleblower is an employee, former employee, or member of an organization, especially a business or government … Continue reading
Docs Using Medtronic Spine Devices Getting Big Payoffs
< "http://www.yourlawyer.com/practice_areas/defective_medical_devices">Medtronic Inc.’s payments to a group of spine surgeons at a Louisville, Kentucky hospital are raising questions about possible kickbacks. According to a report in The Wall Street Journal, from 2004 through 2008, the group of surgeons from Norton … Continue reading
Zonegran Whistleblower Lawsuit Settled
Elan Corporation PLC and its US subsidiary Elan Pharmaceuticals Inc. have agreed pay more than $203 million to resolve criminal and civil liability arising from the illegal promotion of the epilepsy drug < "http://www.yourlawyer.com/topics/overview/epilepsy_drugs">Zonegran, the US Justice Department announced today. … Continue reading
Drug Company Whistleblower Lawsuits Settled for $421 Million
Abbott Laboratories Inc., B. Braun Medical Inc. and Roxane Laboratories Inc. have agreed to pay $421 million to settle False Claims Act allegations, the US Justice Department announced yesterday. The drug makers and their entities were accused in whistleblower lawsuits … Continue reading
Drug Makers Top List of Federal Whistleblower Lawsuits
Drug manufacturers were the key payers in government fraud settlements under the False Claims Act, a important whistleblower law, according to an emerging report, wrote Fair Warning. Advocacy group, Taxpayers Against Fraud Education Fund revealed that eight out of the … Continue reading
GlaxoSmithKline to Pay $750 Million to Settle Federal Whistleblower Suit Over Defective Paxil, Other Drugs
GlaxoSmithKline has agreed to plead guilty and pay a $750 million fine to settle a US Justice Department investigation into the manufacture of defective pills, including the antidepressant < "http://www.yourlawyer.com/topics/overview/paxil">Paxil, at its plant in Cidra, Puerto Rico. The government’s case … Continue reading
Environmental Group Objects to Fracking Study Panel Nominee
Fracking opponents aren’t too happy that the Environmental Protection Agency (EPA) has nominated a petroleum engineer to sit on the panel that will review its just-begun study of the health and environmental impacts of hydraulic fracturing. According to the Environmental … Continue reading
